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A B S T R A C T
DamID, a method to identify DNA associating with a particular protein, was originally developed for use in
immortalized tissue culture lines. The power of this technique has led to its adaptation for a number of additional
systems. Here we report adaptations for its use in primary cells isolated from rodents with emphasis on the
challenges this presents. Specifically, we present several modifications that allow the method to be performed in
mouse acutely isolated primary hepatocytes while seemingly maintaining tissue genome architecture. We also
describe the downstream bioinformatic analysis necessary to identify LADs and discuss some of the parameters
and their effects with regards to the sensitivity of the method.
1. Introduction
DamID is a powerful tool complementing chromatin im-
munoprecipitation-sequencing (ChIP-Seq) for identifying genome re-
gions associating with particular proteins [1,2]. A peculiar advantage of
DamID over ChIP-Seq is to identify genome regions in association with
the nuclear envelope. Nuclear envelope interactions with specific genes
change during differentiation and this adds an additional layer of reg-
ulation that includes tight temporal regulation on top of transcription
cascades to important genes for the differentiation process [3,4].
DamID has also identified more rapid changes occurring at the nuclear
envelope for example in lymphocyte activation [5]. Thus determining
nuclear envelope connections to chromatin in different tissues and
developmental stages is an important currently under-developed area
for understanding developmental and immune disorders as well as
fundamental mechanisms of genome regulation in general. However,
while the nuclear envelope has extensive interactions with chromatin,
these are difficult to recover by ChIP-Seq because both nuclear en-
velope transmembrane proteins (NETs) and lamins are highly inter-
connected and inherently insoluble [6–8].
The original LaminB1-DamID gets around this by fusing the in-
soluble nuclear Lamin B1 protein with a bacterial Dam methylase. The
fusion protein localizes to the nuclear envelope while the Dam me-
thylase recognizes GATC motifs in the DNA in its proximity and cata-
lyzes the addition of a methyl group to the adenine to form m6A. This
kind of DNA methylation is unique to prokaryotes, and permits the
identification of DNA in close proximity with the nuclear envelope in
higher organisms. The use of LaminB1 is advantageous for the higher
eukaryotes that express them because this protein is exclusively at the
nuclear envelope due to its permanent farnesylation [9] and it is a very
abundant protein, present at roughly 9.5million copies per mammalian
cell nucleus [10,11]. The DNA labelled with m6A can then be recovered
and identified using microarrays or sequencing [1,2,12]. To ensure the
specificity of the DNA labelling in DamID, in addition to expressing the
Dam methylase fused to the protein of interest, the Dam methylase is
also expressed alone as a soluble nuclear protein to label DNA that is
accessible throughout the nucleus, and traces of both proteins are then
compared. This accounts for chromatin accessibility variation and it
works particularly well when the fusion is to a nuclear envelope protein
because much of the peripheral DNA appears to be less accessible to the
free Dam methylase. The proteins are expressed at a very low level in
the procedure to reduce background and maintain specificity. This is
achieved by relying upon the leakiness of the Drosophila melanogaster
minimal heat shock protein promoter, rather than induction. Following
in situ labeling, genomic DNA is extracted from cells and then the un-
iquely methylated GATC-motifs are specifically cut by the DpnI re-
striction enzyme. Subsequent digestion with DpnII, which only cuts at
unmethylated GATC sequences, facilitates the selective amplification of
genomic fragments that are flanked by methylated GATC motifs after
ligation of adaptors to the DpnI-exposed ends. Because a wide range of
fragment sizes would be expected from the genome, the resulting DNA
appears as a smear on agarose gels with no clearly delineated individual
bands. The amplified fragments were originally identified using whole
genome microarrays, but are now more commonly identified by
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sequencing due its simplicity and the wide range of organisms for which
the procedure is now used that include mammalian cells [1,4,13],
Schizosaccharomyces pombe [14], Caenorhabditis elegans [15], Drosophila
melanogaster [16], and Arabidopsis thaliana [17]. Plotting the relative
enrichment of genome sequences labelled by the Dam methylase fused
to Lamin B1 compared to those labelled by the Dam methylase alone
identifies the genomic regions associating with the nuclear envelope,
termed lamin associated domains or LADs.
A major advantage of DamID over ChIP is that DamID does not rely
on the availability of antibodies and avoids issues related to epitope
masking [18]. Also, DamID does not require crosslinking so the inter-
actions between DNA and the protein of interest are more likely to be
direct than in ChIP. Resolution in DamID is limited to the local fre-
quency of GATC motifs, although this is unlikely to be a significant
problem at least for mouse or human cells. In Drosophila GATC sites
within 2.5–5 Kb of a locus where the Dam methylase is bound have
been reported to be efficiently methylated [19], and GATC sites are
very frequent in the mouse and human genomes with a median DpnI
fragment size of around 260 bp, and 99.9% under 3 Kb.
Previously, we modified the DamID procedure when we used it to
follow gene positioning changes during myogenesis because we found
that in muscle cells there was a very high background of mitochondrial
genomes carrying similar methylation, which needed to be overcome
[3]. Indeed, in many different cell types and differentiation systems
additional modifications are likely to be required for effective appli-
cation of the DamID approach. In this paper we present an adaptation
for use of DamID in freshly isolated primary liver cells. We highlight the
specific challenges the protocol presents using DamID in primary cells,
provide experimental workarounds and solutions, and we describe the
bioinformatic analysis necessary to define LADs including the most
important parameters and their effect on the detection of LADs. Al-
though our particular approach is focused on using Lamin B1-Dam fu-
sions, this procedure can be adapted to other soluble proteins of in-
terest, considering their general abundance, distribution and
localization.
2. Materials and methods
2.1. Isolation and culture conditions for primary mouse hepatocytes
The specific procedure described here used C57BL/6 mice, though it
should be generally applicable to different mouse strains and other
mammals. The animals were maintained at a constant temperature of
22 °C, 12 h light/dark cycle, and given access to food and water ad li-
bitum. All the experimental procedures were carried out in accordance
with European Directive (2010/63/EU) and approved by the
Institutional Animal Care and Use Committee of Perugia University and
the Italian Ministry of Health. Primary hepatocytes were isolated
from12 to 16-week old male mice by a two-step collagenase perfusion
method, as previously reported [20], with modifications as described
below. Specifically, the portal vein was cannulated with a 21G needle
and the liver was perfused with a Ca2+- and Mg2+-free buffer (HBSS pH
7.4, plus 0.5mM EGTA, 25mM HEPES, 100 U/ml penicillin, and
0.1 mg/ml streptomycin) at a rate of 5ml/min for 5min at 37 °C (visual
reference of perfusion procedure in mice can be found at https://bit.ly/
2mf71yw). Next, collagenase solution (DMEM low glucose with 0.2 g/L
CaCl2 and 0.01 g/L MgSO4, supplemented with 0.3mg/ml collagenase I
(Sigma, C0130), 15 mM HEPES, 100 U/ml penicillin, and 0.1mg/ml
streptomycin), equilibrated at 37 °C, was perfused to digest the liver
(about 35ml/animal). After digestion, gall bladder was removed and
the liver was placed in a Petri dish with 10ml of warm (37 °C) col-
lagenase solution. Hepatocytes were released from the liver capsule by
tearing liver lobes with two pairs of forceps and gently shaking the
tissue under a tissue culture hood to obtain a cloudy cell suspension
that then was filtered through a 70 µm nylon cell strainer (Corning®,
431751). Intact hepatocytes were washed with complete cell culture
medium (William’s E medium containing 5% fetal bovine serum (FBS),
2 mM L-glutamine, 0.1 µM insulin, 0.1 µM dexamethasone, 100 U/ml
penicillin, 0.1 mg/ml streptomycin, and 40 µg/ml gentamicin) by three
rounds of centrifugation at 50×g for 2min at 4 °C. Cells were re-
suspended in complete culture medium and cell count was performed
by trypan blue exclusion assay. Only preparations with a viability ex-
ceeding 85%, were used for the experiments. Cells were seeded at
60–70% of confluence into dishes precoated with collagen from rat tail
(5 µg/cm2) in complete culture medium. Cells were allowed to attach
for 2 h, gently washed once with PBS, then fresh medium was added for
additional 2 h. Thereafter, cells were grown in complete serum-free
culture medium. The primary hepatocytes were cultured at 37 °C in a
humidified 5% CO2 incubator with daily medium renewal. Immediately
after isolation, hepatocytes were tested for mycoplasma infection by a
PCR based method using genomic DNA as template (20–40 ng per re-
action), as previously described [21], because the mycoplasma genome
has similar methylation to that of the DamID procedure and can swamp
the relevant signal. Primary hepatocyte cultures are usually limited to
short-term applications due to the rapid loss of their differentiation
state and proliferative potential progressively during cell culture,
starting from 24 h of incubation. Considering that the eradication of
mycoplasma infection with appropriate antibiotics requires longer
treatment exposure, mycoplasma positive preparations were discarded.
2.2. Production of lentivirus in HEK293FT cells
DamID relies on the efficient transfer of a transgene expressing low
levels of the protein of interest fused to a bacterial Dam methylase [2].
The preferred approach for the transfer is lentiviral transduction, which
allows the insertion of DNA into the nucleus of a wide range of cell
types, both proliferating and non-proliferating. Lentivirus particles are
typically produced by transfection of separate plasmids encoding all the
necessary lentiviral components to package the target transfer DNA that
is encoded in another plasmid. Human HEK293FT cells are often used
because they are easy to transfect and they have been engineered to
produce large T-antigen from SV40 virus, which induces the in-
tracellular replication of plasmids bearing the SV40 origin of replica-
tion, thus greatly multiplying the copy number of each transfected
plasmid and increasing lentiviral titers. We generate amphotropic len-
tivirus pseudotyped with the vesicular stomatitis virus envelope gly-
coprotein (VSV-G), which can infect both human and mouse cells.
Lentivirus with different tropisms can be generated by using the ap-
propriate plasmids encoding for other viral envelope proteins.
For each experimental condition three lentiviruses are required: 1)
protein of interest, in our case LaminB1, fused to the bacterial Dam
methylase, 2) Dam methylase alone, and 3) empty vector, a technical
control. Comparing the signal levels from Dam-LaminB1 against soluble
Dam alone controls for differences in accessibility to chromatin and
sequence-dependent biases during subsequent PCR amplification. The
empty vector control is very important, as in mammalian cells there
should not be any other source of m6A than the DNA methylated by the
exogenously introduced Dam-encoding constructs. The presence of
amplified DNA in the empty vector control is often an indication of
mycoplasma contamination or some other source of prokaryotic infec-
tion. If this happens, prokaryotic DNA would comprise a very high
proportion of the recovered methylated DNA, severely compromising
the experiment.
2.2.1. Culture conditions
HEK293FT cells (Clontech) were grown at 37 °C and 5% CO2using
high glucose DMEM supplemented with 10% fetal bovine serum, 6mM
L-Glutamine, 50 U/ml penicillin, 0.05mg/ml streptomycin, and 0.5mg/
ml Geneticin (to maintain expression of large T-antigen). Cells were
split by trypsinization 1:4–1:6 when they reached 80–90% of con-
fluence. It is important to avoid letting the cells get too confluent and to
ensure the cells are actively dividing to maximize transfection
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efficiency.
2.2.2. Transfection
Non-replicative self-inactivating lentiviruses were generated by co-
transfection of psPAX2 (lentiviral packaging plasmid), pMD2.G (VSV-G
envelope protein) and transfer vectors encoding either a bacterial Dam
methylase fused to LaminB1 (pLgw Dam-LaminB1), Dam methylase
alone (pLgw Dam) or an empty vector (pLgw-empty) as a control.
Lentiviral plasmids and the DamID backbone vectors are available at
Addgene. Transfer vectors used here were a gift from Bas van Steensel.
This is a 2nd generation lentiviral system is sufficiently safe for most
purposes. It's worth noting, however, that there are other systems (3rd
and 4th generation) that confer increased levels of safety. The drawback
is that they typically yield lower viral titres because they require the co-
transfection of a larger number of plasmids. The user should consider
the nature of the gene of interest and consult their local regulations
before deciding whether a 2nd generation system or a safer alternative
should be employed.
For each transfection we prepared one 1.5 ml microfuge tube con-
taining 4.6 µg of psPAX2, 2.8 µg of pMD2.G and 7.5 µg of transfer vector
in 1mlOpti-MEM, and one 15ml tube with 36 µl of Lipofectamine 2000
in 2mlOpti-MEM. Following a 5min incubation at room temperature,
the DNA solution was added to the Lipofectamine, vortexed briefly, and
incubated at room temperature for 15–20min. Meanwhile, HEK293FT
cells were harvested, counted with a hemocytometer, and seeded in
10 cm dishes at 6× 106 cells per dish, in 5ml of culture medium. It is
not necessary to omit antibiotics during transfection, but it may help to
obtain higher yields. After incubation, the lipofection mix was added to
the cells, still in suspension, mixed gently, and the dishes placed back
into the incubator overnight.
2.2.3. Lentivirus harvest and storage
Transfection medium was removed after 16–18 h and 12–14ml of
fresh culture medium added to each 10 cm dish. The supernatant was
harvested 48 h later and centrifuged for 15min at 500×g to remove
cellular debris. The supernatant was carefully aspirated into fresh tubes,
LentiX Concentrator (Clontech) added in a 3:1 ratio, mixed gently, and
incubated overnight at 4 °C. Lentivirus particles were then precipitated
by centrifugation at 1500×g for 45min, and resuspended in 200–400 µl
Opti-MEM. The lentiviral solutions were divided into 20–50 µl aliquots
and stored at −80 °C. It is important to avoid freeze-thaw cycles to
ensure the viability of the virus. Alternatively, instead of using poly-
ethylene glycol (PEG) based reagents such as LentiX that allow the use
of benchtop centrifuges most commonly found in tissue culture labs, it
is possible to precipitate the lentivirus by ultracentrifugation, as de-
scribed [3,21].
2.3. Optimization of lentiviral transduction
To perform lentiviral transduction of primary mouse hepatocytes
under optimal conditions for successful application of the DamID pro-
tocol, cells are initially tested for tolerance to polybrene, a transduction
enhancer, and for the reporter gene expression levels (e.g., EGFP).
Polybrene favors lentiviral particles association with target cell plasma
membranes by reducing negative charge repulsion forces. However,
excessive amounts can lead to apoptosis, so it is important to test for
toxicity first and use a concentration that does not cause harm to cells
(at least in the relatively short period of the infection), and that it does
not interfere with the experiment in some other way. There are other
transduction enhancers that can be used, such as protamine sulphate,
retronectin, DEAE-dextran, and various proprietary commercial others.
In fact, we preferred protamine sulphate in the case of mouse myogenic
differentiation system because polybrene appeared to interfere with
differentiation [21].
2.3.1. Assessment of polybrene toxicity
Freshly isolated hepatocytes were seeded into 24-well plates
(0.1× 106 cells/well) and after 4 h they were incubated with serum-
free culture medium in the presence or in the absence of epidermal
growth factor (EGF, 40 ng/ml) and increasing polybrene concentrations
(0–10 µg/ml). The medium was replaced daily by fresh medium sup-
plemented with EGF and polybrene. Cell morphology changes were
periodically monitored by direct observation with a light microscope;
images were acquired by a phase-contrast microscope equipped with a
digital camera. After 72 h of incubation in the presence of polybrene,
cell viability was assessed by using a modification of the 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) reduction
assay, which has been applied to assess cytotoxicity in hepatocytes
[22,23]. Cells were plated into 6-well plates at a density of 0.5× 106
cells per well and, after the treatments, they were detached by trypsi-
nization. Recovered cells were resuspended in 0.5 ml of PBS containing
0.5 mg/ml of MTT and incubated for 1 h at 37 °C with gentle shaking.
After centrifugation (5min at 300×g), cell pellets were dissolved in
1ml of dimethyl sulfoxide (DMSO) by pipetting and cellular debris
were removed by further centrifugation2 min at 13000×g. Absorbance
of the reduced MTT product (formazan) was measured at 595 nm by a
UV–VIS spectrophotometer (UVmini-1240, Shimadzu).
2.3.2. Analysis of transduction efficiency
To test the efficiency of transgene expression in isolated mouse
hepatocytes, attached cells were grown for 18 h in culture medium
enriched with EGF (40 ng/ml), polybrene (6 µg/ml), and EGFP-en-
coding lentiviral particles previously made using pRRLSIN.cPPT.PGK-
GFP.WPRE (Addgene). Transduction medium was then removed, he-
patocytes were washed with PBS, and wells were replenished with fresh
culture medium containing EGF on a daily basis. For the analysis of
exogenously expressed protein by immunoblotting, cells were seeded
on 6-well plates (0.5× 106 cells/well) and cultured in 0.8ml of trans-
duction medium per well with the addition of different amounts of
lentiviral preparation (0, 20 µl, 50 µl, 100 µl, and 160 µl). Whole cell
protein lysates were obtained at 72 h after transduction by the direct
addition of 150 µl per well of boiling lysis buffer (60mMTris-HCl pH
6.8, 10% glycerol, 0.1% SDS, 0.1% triton X-100, 2mM EDTA, and 1x
protease inhibitor cocktail). After protein quantitation by Bradford
assay, samples were adjusted to 2% SDS, 1.5% β-mercaptoethanol, and
0.05% bromophenol blue, subjected to SDS-PAGE (30 µg of protein per
lane), and transferred to nitrocellulose or PVDF membranes. Filters
were probed overnight with anti-GFP (Roche, 11814460001; 1:1000) or
anti-β-tubulin (Proteintech, 66240-1-lg; 1:5000) primary antibodies
and afterwards with a HRP-conjugated goat anti-mouse secondary an-
tibody (Bio-Rad, 1706516; 1:5000). Proteins of interest were visualized
using ECL reaction and images were acquired by a ChemiDoc™ imaging
system. To directly visualize EGFP-derived fluorescence in transgene-
expressing cells, hepatocytes were grown on 12mm coverslips (Knittel
Glass) inserted into 24-well plates (0.1× 106 cells/well) and trans-
duced for 72 h as described above, with 1/8 of starting medium volume
of the lentiviral preparation encoding for the EGFP. After the incuba-
tion period, cells were fixed with 4% PFA and quenched in 50mM
ammonium chloride for 15min at room temperature [24]. Nuclei were
stained with Hoechst 33,342 (Thermo Fisher Scientific, H3570) and
coverslips mounted on ProLong™ Diamond antifade mountant (Thermo
Fisher Scientific, P36970). The slides were analyzed with a confocal
microscope system (Zeiss LSM 710, Oberkochen, Germany) through the
excitation of EGFP at 480 nm and the acquisition of emitted fluores-
cence at 510 nm. The use of the EGFP reporter to visualize transduced
cells is merely a quick but crude method to adjust viral titre production
from batch to batch, as that is where most of the variation in the len-
tiviral production seems to occur, due to variations in cell culture and
transfection conditions. It is crude, because different constructs will
lead to different lentiviral production efficiencies. However, the DamID
technique seems robust enough when driving the LaminB1-Dam
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expression from the uninduced inducible heat shock protein promoter,
that a relatively wide range of viral titres can be used and exact titre
calculations are not needed. If one batch appears to require significantly
more EGFP lentiviral supernatant in order to achieve a comparable
level of transduction to another batch, adjusting the amounts of the rest
of the supernatants within the same batch accordingly seems to work
well. In order to minimize variations, it is recommended to prepare
good quality lentiviral vector DNA in large amounts and store in ali-
quots.
2.4. DamID-experiment
2.4.1. Preparation of DamID cells
Cells were isolated as outlined above, seeded into 6-well plates at a
density of 0.5× 106 cells per well, allowed to adhere for 4 h, and
transduced overnight with serum-free complete culture medium con-
taining 40 ng/ml EGF, the predetermined amount of polybrene (6 µg/
ml) and empty, Dam alone-, orDam-LaminB1-encoding lentiviruses
(transduction medium). The transduction medium was then replaced
with fresh serum-free complete medium with EGF and transduced he-
patocytes were left in the incubator for a further 48 h to ensure suffi-
cient Dam-fusion protein expression and, therefore, methylation of the
DNA sequences interacting with Lamin B1.
2.4.2. Genomic DNA extraction
After 72 h of transduction, genomic DNA was extracted by using the
DNeasy blood and tissue kit (Qiagen, 69504) according to manu-
facturer’s instructions. Briefly, cells were trypsinized, centrifuged at
300×g for 5min and resuspended in 0.2ml of PBS. RNAseA (0.1 mg/
ml) treatment was performed for 3min prior the addition of cell lysis
buffer. Complete cellular digestion was obtained through the incuba-
tion with proteinase K (30min at 56 °C). Digested samples were loaded
onto spin columns for genomic DNA purification. Elution of genomic
DNA from the columns was performed twice with 100 µl of buffer AE
(preheated at 65 °C) followed by incubation (1min at room tempera-
ture) and centrifugation at 6000×g for 1min. Next, DNA was pre-
cipitated by the addition of 0.1 volumes of 3M sodium acetate (pH 5.4),
10 µg of glycogen, and 3 volumes of 100% ethanol. Samples were in-
cubated at −80 °C for 30min and DNA was pelleted at 13000×g for
15min at 4 °C. DNA pellets were washed with 400 µl of 70% ethanol by
centrifugation at 13000×g for 5min, at 4 °C. Air-dried DNA was re-
suspended in 13 µl of TE-lowE (10mMTris-HCl pH 8.0, 0.1 mM EDTA)
buffer at 56 °C for 1 h. DNA concentration was determined by a mi-
croplate reader (Infinite® 200 PRO, TECAN) equipped with a
NanoQuant plate.
2.4.3. Enrichment of Dam-methylated DNA
DNA methylated by the exogenous Dam constructs can be specifi-
cally amplified by PCR, after processing it to obtain DNA fragments
flanked by methylated GATC sequences to which adaptors have been
ligated. The whole process has been designed to be performed using a
single PCR tube to minimize losses. For each experiment 3 aliquots of
2.5 µg are required. First, two aliquots of 2.5 µg of genomic DNA are
digested overnight at 37 °C with 10 units of DpnI in a total volume of
10 µl using restriction buffer 4 from NEB. DpnI only cuts GATC se-
quences when the adenine is methylated. An additional 2.5 µg DNA
aliquot should be set in a parallel reaction lacking DpnI, as a control.
This control should not generate any significant amount of amplifica-
tion. If it does, it would suggest widespread DNA fragmentation has
occurred, such as apoptosis-induced DNA cleavage and the samples
should not be used. Note that a pretreatment with alkaline phosphatase
could be used to prevent ligation of the DamID adaptors to the damaged
DNA, and thus its amplification, however we recommend this only as a
last resort if a new sample cannot be easily obtained, because a large
amount of apoptotic cells in the sample could affect the resulting
DamID profile. After digestion, DpnI is inactivated by heating to 80 °C
for 25min, and then the dsAdR adaptor (made by annealing oligos AdRt
CTAATACGACTCACTATAGGGCAGCGTGGTCGCGGCCGAGGA and
AdRbTCCTCGGCCG) is ligated to the DpnI digested DNA. This is
achieved by adding 2 µl of 10× T4 ligase buffer (NEB), 5 units of T4
DNA ligase (NEB), dsAdR adaptor to 2 µM, and nuclease-free water to a
final volume of 20 µl, and incubating at 16 °C for 16 h. Omit the T4
ligase on one of the duplicate DpnI positive reactions. This control is to
ensure that amplification is not due to dsAdR-independent PCR of si-
milar sequences that might be present in the genome. If the yield of
DNA is low and there is not enough for all the controls, this one is
probably the safest one to omit. Ligase can be inactivated by heating at
65 °C for 20min. Unmethylated GATC sequences are then digested
using DpnII (which cuts only unmethylated GATC) by adding 5 µl of
10xDpnII buffer (NEB), 10 units of DpnII (NEB), and nuclease-free water
to make up a total of 50 µl, and incubated at 37 °C for 1 h.
At this stage, DNA fragments that were flanked by methylated DNA
can be enriched by PCR, as they should have a dsAdR adaptor at both
ends. Transfer 5 µl of the products (about 250 ng DNA) to a fresh PCR
tube, and add 1.25 µl of 50 µM AdR-PCR primer (GGTCGCGGCCGAG
GATC), 1 µl of 10mM dNTP mix, 5 µl of 10× PCR buffer and 1 µl of
Advantage PCR enzyme mix (Clontech 639105), and nuclease free
water to 50 µl. We have tried other PCR reagents but this specific kit is
superior to anything else we have tried. Run the following program:
[10min @ 68 °C]× 1, [3 min @ 94 °C; 5min @ 65 °C; 15min @
68 °C]×1, [1 min @ 94 °C; 1min @ 65 °C; 10min @ 68 °C]×4, [1 min
@ 94 °C; 1min @ 65 °C; 2min @ 68 °C]×18. Run 3 µl of each reaction
on a 1% agarose gel to assess quality and amplification yield. On a good
experiment we expect to see a smear, typically between 200 and
1500 bp, on the products from Lamin B1-Dam and Dam alone, and
nothing on any of the negative controls. If the negative controls are
clear, then the amplified DNA is cleaned up using the Qiagen QIAquick
PCR purification kit and the DNA quantified. How much DNA is re-
quired for sequencing will depend on the company used to carry it out
and the sequencing platform they use. We typically pooled together the
products from 4 to 5 PCRs as described above, and purified the DNA
together. This way we obtained more than the 2.5 µg that our chosen
sequencing facility required. More or fewer PCRs may be required in
order to meet the requirements of different sequencing facilities. It is
important to keep the number of cycles relatively low in order to avoid
excessive bias towards more abundant sequences inherent to PCR. For
this reason we do not recommend increasing the number of cycles
stated here.
2.5. DNA sequencing and data analysis
We have performed LaminB1-DamID experiments with as few as
20million 'clean' reads for human or mouse genomes with some degree
of success, although we would recommend at least 30–40million
minimum. By clean reads, we mean the number of sequences obtained
per sample after filtering contaminants and sequences that map to
multiple regions in the genome. Noisy data due to suboptimal sequence
coverage makes analysis more complicated and reduces reliability,
which makes the use of multiple replicate experiments more important.
One way to deal with noise is to apply local smoothing, but that reduces
the spatial resolution. There is no substitute for a healthy number of
good quality sequence reads to obtain good quality results.
2.5.1. Sequencing data processing
The DNA obtained at step 2.4.3 was sent for sequencing offsite. We
have generally used Beijing Genomics (BGI), and prepared the DNA
according to their specifications. For example, using the Illumina HiSeq
2000 platform in conjunction with 90 bp read lengths, we submitted
2–2.5 µg of DNA per sample. Sequencing libraries were prepared by BGI
by randomly fragmenting the DamID DNA and ligating sequencing
adaptors to the ends. We have been able to obtain up to 45million reads
per sample, running four samples multiplexed per well. These details
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will depend on the sequencing platform and facility used and so it is
important to calculate expected read depth before engaging sequencing.
Some facilities will provide sequence data that have already been fil-
tered to remove low quality reads in addition to the raw data, and some
will just provide the raw sequences. Raw data can be easily custom-
filtered using the Java tool FastQC (http://www.bioinformatics.
babraham.ac.uk/projects/fastqc). Sequences from each sample were
then mapped to the mouse genome mm9 NCBI build 37 using the
Burrows-Wheeler Aligner (BWA), and sequences mapping to mi-
tochondria or to ambiguous locations were eliminated [25]. It is typi-
cally expected to use the latest build, but note that if comparing to
previously published DamID experiments it is important to also for
those comparisons match by using the same build.
For analysis, we quantified 'normalized counts' per genomic DpnI
fragment as the proportion of the total reads in that sample that overlap
with each fragment. This is done for both LaminB1-Dam and Dam-only
samples. The signal for each DpnI fragment is then represented as the
log2 ratio between LaminB1-Dam and Dam-only normalized reads,
followed by quantile normalization of the ratios using the R/
Bioconductor package Limma [26]. The results can be output as a BED
format file variant. This is a text format that contains genomic co-
ordinates, as well as optional labels and numerical data corresponding
to the signal values per fragment. While these files are simple to un-
derstand, they are also cumbersome, so to facilitate displaying data
they should be converted to a compressed binary format such as
BigWig. This can be achieved with a tool such as 'wigToBigWig'
(https://www.encodeproject.org/software/wigtobigwig). The resulting
files can be imported into the Integrated Genome Viewer (IGV, https://
software.broadinstitute.org/software/igv) for visualization, where
LADs appear as regions with positive signal, separated by interLADs.
The data can appear ‘noisy’ both when sequence coverage is suboptimal
and due to aspects of the biology of the experiment. The 'noise' is ob-
vious when zooming into interLADs which then may appear to have
frequent spurious positive signal fragments. The reason the noise is not
apparent when zooming out is that DamID profiles appeared smoothed
on the screen. The best way to deal with noisy data is to produce better
data, but that is not always an option for financial or technical reasons.
In that case, it is possible to apply gentle smoothing at the cost of losing
some spatial resolution and dynamic range. Considering that the
median DpnI fragment size in mouse is 260 bp and that 95% are under
1238 bp, a smoothing factor of 20 would be reasonable, where the value
assigned to each DpnI fragment is substituted by the average of the 20
fragments surrounding it. This would lose only a few Kb of resolution
but the cleaner profiles make LAD detection easier. It is important to
consider that in smoothing the data as indicated, DpnI fragments with
high read counts are treated just the same as DpnI fragments with low
read counts, whose quantitation is less reliable. While this can work
well enough, as illustrated here, there are other alternatives that one
could consider. For example, smoothing before normalization or
quantifying the reads using bins of a constant size rather than DpnI
fragments, can produce good results too and may be less influenced by
the mix of high and low read count fragments. Experimenting with
different sized bins is recommended, but we find that 2–5 Kb bins is
usually a good starting point.
2.5.2. Determination of LADs
LADs can be visually observed using a browser like IGV. LADs are
thought to typically range from a few tens of kilobases to several
megabases long, and cover up to 50% of the genome. This does not
necessarily mean that half of the genome is located at the nuclear
periphery of the nucleus at any one time, but it is probably a reflection
of the variability in LADs between individual cells in the population
[27]. To determine the coordinates of LADs, there are various peak
finding tools available. We prefer the circular binary segmentation
(CBS) algorithm used in the Bioconductor package DNAcopy [28].
DNAcopy will use the BED files generated in Section 2.5.1 and segment
the genome into subregions of equivalent signal, producing another
BED file as output. This output needs to be processed in order to obtain
the final list of LADs: remove genomic gaps, apply threshold, merge
regions and remove small regions. All these operations are performed
on large but simple text files using very simple code in R with the help
of tools from Bedtools, a software suite that provides a wide range of
functions for the manipulation of BED files [29]. First, CBS does not
take into consideration gaps in the reference sequence, so it is necessary
to remove those, otherwise artifactual LADs will be generated that span
large regions for which no information exists. Genomic gap tables were
downloaded from the UCSC genome browser and gaps removed from
the CBS output using 'bedtools subtract'. Then, a threshold is used
where anything below it is eliminated. A threshold of zero is commonly
used, but it can be useful to experiment with values up to 0.1 or higher,
especially if the data are noisy. Next, the genomic coordinates that CBS
produces may contain overlaps. Merging overlapping regions can be
performed with 'bedtools merge', which also allows to specify whether
to merge regions that do not overlap but are closer than a user-defined
distance. We find that merging values of 5 to 8 Kb give good results
without resulting in unusual fragmentation of big LADs. At this point,
there are usually a large number of very small putative LADs. Some of
these may be genuine, but the smaller the LAD, the lower the con-
fidence level. Having experimental replicates becomes thus very im-
portant if the smaller LADs are to be considered. Without replicates, we
usually sacrifice the smaller LADs in order to maintain confidence in
our data, cutting anything below 5–30 Kb, depending on how noisy the
data are. The user must investigate the effect that various parameters
have on the data, and choose what appears most reasonable. If there are
regions whose positions have previously been demonstrated by FISH,
they can provide some useful controls in order to choose the various
parameters above.
3. Results and discussion
The original DamID procedure was developed for use with tissue
culture cancer cell lines [2]. We previously found that several mod-
ifications were needed for an in vitro muscle differentiation system due
to high backgrounds of methylated DNA from mitochondria that ac-
cumulate within invaginations of muscle nuclei as well as several other
factors [21]. In applying DamID to primary hepatocytes isolated from
adult mouse livers we encountered the need for several additional
modifications to the DamID procedure which we describe here. The
application of the Lamin B1-DamID assay in primary cells allows the
determination of the peripheral genome organization peculiar to cells
in tissue as this may differ from that of cancer cell lines grown in
perpetuity in 2D monolayers. Here, we present a detailed workflow
from cell isolation to sequencing data analysis (Fig. 1) which enables to
use tissues instead of cell lines for the application of the DamID tech-
nique in mammalian cultures, and, for the first time, specifically in
primary mouse hepatocytes.
3.1. Primary mouse hepatocyte culture optimization
In order to successfully apply the DamID protocol in primary mouse
hepatocytes, a proper isolation technique should be mastered to pro-
duce viable cultures. A detailed methodology and equipment descrip-
tion have been published [20,30,31]. The whole purification procedure,
from the animal anesthesia to cell plating, was completed as quickly as
possible (in 1–1.5 h) for the purpose of obtaining a sufficient number of
viable cells. Freshly isolated hepatocytes were observed under a light
microscope immediately after the isolation, and following 2 or 4 h of
culture (Fig. 2). By this time cells had sufficiently recovered from the
stress of isolation and showed luminous and round-shaped cytoplasm,
clear and distinct nuclei (mostly binucleated) and the cuboidal mor-
phology that resembles liver tissue organization. Plating the cells at
5× 104/cm2 allowed to reach the confluence and to form a monolayer
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after 24 h of culture, which is crucial to maintain hepatocyte phenotype
and metabolic activity. The original DamID procedure requires main-
tenance of the cell cultures typically for three days after transduction
for sufficient Dam-fusion protein expression and for achieving optimal
Dam activity and labeling of specific DNA loci. Hepatocytes isolated for
in vitro studies are prone to losing their defined differentiation state
progressively with the time of culture, as can be determined by their
obtaining a more fibroblast-like aspect by 72 h. To prevent loss of dif-
ferentiation, at least for the duration of DamID experiments, the culture
medium used was optimized for maintaining liver-specific functions of
hepatocytes by removing serum and supplementing with insulin, dex-
amethasone, and EGF, which helped in slowing the dedifferentiation
process and in increasing culture longevity [32–35]. Particularly, EGF
exposure was critical in the application of the DamID protocol in he-
patocyte cultures on the basis of its strong mitogenic and anti-apoptotic
activity in liver cells [36–39]. The spontaneous formation of apoptotic
cells in hepatocyte cultures could produce competition by apoptotic
DNA fragments in the adaptor ligation and subsequent PCR amplifica-
tion steps of methylated sequences. For this reason, the T4 ligase-minus
control is recommended. In addition, the promotion of mitotic expan-
sion in hepatocytes (otherwise quite quiescent when cultivated in vitro)
permitted the correct maintenance/reassembly of chromatin archi-
tecture and localization of expressed Dam-tagged protein of interest.
The absence of mycoplasma infection was detected by performing a
specific PCR amplification protocol on isolated genomic DNA, which
ensures enough sensitivity even for low infection levels [21]. The pre-
sence of contaminating m6A methylated DNA derived from the pro-
karyote can otherwise interfere with the analysis of specific methyla-
tion marks generated from the exogenously expressed Dam-fusion
proteins that bind to target sequences and thus testing here revealed no
Fig. 1. Schematic representation of DamID-Seq
method applied to primary mouse hepatocytes. A cell
culture optimization step (1) was included to find the
optimal culture conditions to obtain the efficient
methylation of target DNA sequences in cells trans-
duced with Dam-encoding constructs (2) and
straightforward sample processing (3).
Fig. 2. Phase contrast images of primary hepatocytes. Cells were observed right following seeding or after 2–4 h of culture. Objective magnification, ×10.
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mycoplasma in the isolated cells.
3.2. Determination of optimal transduction conditions for Dam activity in
primary mouse hepatocytes
The DamID technique has the potential to be adapted to any cell line
or animal into which the Dam-expressing constructs can be efficiently
delivered. The differentiation status of a particular cell type strongly
influences the ability of the cell to uptake exogenous DNA. In general,
fully differentiated cell types are much more difficult to be genetically
engineered than proliferating and undifferentiated cell types. Protocols
for applying the DamID method in a variety of immortalized cell lines
Fig. 3. Assessment of polybrene toxicity in primary mouse hepatocytes. Cells were cultured for 72 h in the absence or in the presence of EGF with increasing amounts
of polybrene (0–10 µg/ml). Cell morphology was evaluated under a phase contrast microscope and images were taken at the indicated times. Arrows indicate
cytoplasmic vacuolization. Images magnification, ×20.
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or primary cells have already been described, but none for primary
mouse hepatocytes yet [2,21]. Despite the presence of some reports in
the literature, primary hepatocytes are relatively resistant to most
plasmid DNA transfection procedures due to their lack of proliferation
capacity in vitro, which precludes foreign DNA to access the nuclear
transcriptional machinery that for most methods requires nuclear en-
velope breakdown in cell division. Electroporation-based methods, such
as nucleofection, could be used as an alternative for hard-to-transfect
cells, although with low efficiencies (< 5%) and high toxicity in pri-
mary hepatocytes (personal observations). For this reason, we opti-
mized a lentivirus-based transgene delivery for our DamID purpose,
taking advantage of the charge negating agent polybrene and the high
transduction efficiency, even in non-dividing cells, of VSV-G
pseudotyped lentiviral particles encoding for native Dam or Dam-Lamin
B1 fused proteins. Lentiviral transduction was also chosen over trans-
fection because plasmid DNA generated in most routinely used bacterial
strains will also harbor the m6A methylation so that its amplification
would be likely to outcompete the specifically DamID methyl-tagged
sequences from the genomic DNA during the DamID processing of
samples. In fact, even Dam plasmids isolated from Dam-negative strains
usually harbors detectable amounts of m6A due to leaky expression of
the Dam construct. Transduction of both human and murine primary
hepatocyte cultures has been already established for basic and clinical
studies by using lentiviruses at high titer [40–43].
We investigated the effect of the transduction enhancer polybrene in
primary hepatocytes by the observation of changes in cellular mor-
phology and metabolic activity. Polybrene has been shown to markedly
increase transduction efficiency but it can also negatively affect cell
viability at high concentration [44–46]. After 24 h of treatment with
polybrene there were no major signs of cell damage, even with the
highest concentration (Fig. 3, first and second columns). When hepa-
tocytes were subjected to longer incubation times in the presence of
polybrene (up to 72 h), cell death was observed from the 8 µg/ml
concentration if a standard growth medium was utilized (Fig. 3, third
column). Conversely, when EGF was added to culture medium cells
were protected from polybrene toxicity as shown by the preservation of
hepatic functionality in the shape of intracellular accumulation of al-
bumin granules (Fig. 3, fourth column) [31]. Indeed, the cell monolayer
was maintained, although cytoplasmic vacuolization started to appear
in a dose-dependent fashion from 6 µg/ml of added polybrene (Fig. 3,
arrows). Accordingly, only after 72 h of treatment at 10 µg/ml poly-
brene, cells showed significant reduction in cell viability (> 20%) as
assessed by MTT reduction assay, even in the presence of EGF (Fig. 4).
Hence, 6 µg/ml dose was selected for transduction.
To evaluate gene transduction efficiency in primary mouse hepa-
tocytes, we obtained a lentiviral vector expressing the fluorescent
protein EGFP, under the control of the human phosphoglycerate kinase
(hPGK) promoter. Isolated cells were tested for transgene expression
after 72 h of transduction with different amounts of highly concentrated
lentiviral preparations by Western blot and confocal fluorescence mi-
croscopy analyses. Following transduction, hepatocytes were viable and
showed that the expression levels of the EGFP reporter protein corre-
lated with the increase of the volume of lentiviral particles added to the
culture medium (Fig. 5A). Moreover, approximately 35–40% of cells
were EGFP positive as observed by confocal fluorescence microscopy
(Fig. 5B). In addition to the aforementioned properties, EGF addition to
the culture medium markedly enhanced transgene expression following
lentiviral transduction, as previously described [43,47]. Transduction
efficiency might be improved through the generation of more specific
lentiviral particles, for example carrying the envelope SV-F (Sendai
virus F env) protein, which provides a specific tropism for hepatic tissue
[42,44,48]. However, evidence of successful DamID experiments in cell
cultures with a transduction efficiency around 15% have been reported
[2].
Another important aspect is that expression levels of the Dam fusion
proteins should be very low, nearly undetectable by Western Blot or
fluorescence microscopy, to avoid the production of a noisy background
signal or cellular toxicity as a result of the Dam methylase activity. For
this reason, weak promoters for Dam-encoding vectors should be con-
sidered like the Drosophila minimal heat shock protein promoter
available from the van Steensel lab [49]. Results clearly demonstrated
that lentiviral vector transduction itself did not impair primary hepa-
tocytes cellular viability and it can be applied for performing DamID-
Seq experiments. After these optimizations, the conditions were en-
gaged for obtaining sufficient material from DamID cells for down-
stream procedures and analyses. Using four wells of a 6-well plate,
5–10 μg of genomic DNA were recovered following the purification
step. The Qiagen DNAeasy purification kit is highly recommended for
DamID. All the steps are performed in one tube, starting from 2.5 µg per
Fig. 4. MTT reduction assay on polybrene-treated primary mouse hepatocytes.
Cells were grown in the presence of EGF and treated with increasing con-
centrations of polybrene (0–10 µg/ml) for 72 h. Hepatocytes viability was as-
sessed in cell suspension by the spectrophotometric measurement of MTT dye
reduction (Abs at 595 nm). Results are the mean ± SD of three independent
experiments in duplicate.
Fig. 5. Determination of transduction efficiency of lentiviral vectors in primary
mouse hepatocytes. (A) Western blot analysis of EGFP expression in cells
transduced for 24 h with different amounts of lentiviral-EGFP vector (1/40, 1/
16, 1/8, and 1/5 of starting medium volume), in the presence of polybrene
(6 µg/ml), and cultured for additional 48 h. β-Tubulin was used as loading
control. (B) Confocal fluorescence microscopy analysis of hepatocytes trans-
duced for 72 h, as described above, with the EGFP-encoding lentiviral pre-
paration (1/8 of starting medium volume). Images magnification, ×40. Scale
bar is 20 µm.
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sample, of which only a small proportion will be methylated. The yield
from this kit may be lower than other methods we have tried, but the
purity of the DNA obtained and the consistency of the downstream
reactions make it the optimal method for the present DamID protocol.
3.3. Sequencing and initial data processing
Sequencing depth is probably the single major determinant of the
quality of the data. The quality and amount of DNA submitted for se-
quencing plays an important role in ensuring the quality of the se-
quences obtained. When DNA amounts are suboptimal this can often
result in a large number of redundant sequences produced from a single
amplicon PCR amplification. This can sometimes be observed as pro-
minent discrete bands within the normal smear, although not always. A
normal pattern of amplification is shown in Fig. 6A. Among the non-
reference sequences obtained, it is common to find adaptor con-
catemers that have to be removed. In most cases this does not present a
big problem, but when the starting amount for DamID is smaller than
required this can be significant. In addition to these technical issues,
there are two kinds of 'contaminants' that can make obtaining the de-
sired sequence coverage difficult: mycoplasma and mitochondria. We
would recommend that mycoplasma contamination is checked by PCR
before proceeding to DNA processing for DamID as indicated earlier
(Section 2.1). If there is mycoplasma DNA in the sample, it will be
preferentially enriched and can easily contribute over 95% of the se-
quences recovered, rendering the experiment useless. For that reason, if
mycoplasma is detected, we recommend discarding experimental
samples and starting again. A typical DamID pattern for mycoplasma
contaminated cells is shown in Fig. 6B.
Mitochondrial DNA is also sometimes recovered together with
genomic DNA. In our hands, mitochondrial sequences can comprise
between 7 and 26% of the total number of sequences recovered from
primary mouse hepatocytes. The reasons for this variability are not
clear to us, but the amount of mitochondrial DNA co-purified with
genomic DNA seems to be reproducibly higher in primary cells than in
tissue culture cancer cell lines. For example, in LaminB1-DamID ex-
periments performed with human fibrosarcomaHT1080 cells [50] mi-
tochondrial sequences always represented less than 2% of the total,
while similar experiments in the mouse myoblast cell line C2C12 pro-
duced between 20% and 74% of mitochondrial sequences [3]. It is
difficult to predict how bad the mitochondrial contamination will be in
any given system, so it helps to perform a pilot experiment with a small
number of samples to assess this, in order to better judge what depth of
sequencing is required. When sequencing depth is suboptimal, it can
visually manifest as noise on the DamID profiles. This is most noticeable
on long interLADs, where instead of a uniform long tract of negative
values, a few isolated fragments give strong positive signals. We have
analyzed a single experiment of each of two conditions using primary
hepatocytes, which we simply call Exp1 and 2 (Fig. 7). Exp1 produced
nearly twice the number of useful sequences as Exp2 after filtering out
ambiguous mapping and mitochondrial sequences (Table 1). Although
the DamID profiles are sufficiently good in both, the profile in Exp2 is
noisier and more jagged than Exp1 (Fig. 8A). The signal for each
Fig. 6. Examples of DamID PCR amplification
smears. A) A smear between 200 and 1500 bp is ob-
served only on Dam-only and LaminB1-Dam positive
samples. The empty DamID vector control is negative
because there is no m6A-methylated DNA available
for DpnI cleavage. Dam-methylated DNA that was not
digested with DpnI (DpnI- control) also fails to am-
plify as there are no significant number of broken
DNA ends for the DamID adaptors to ligate to, con-
firming the integrity of the DNA prior to treatment.
Similarly, the non-ligase (Lig-) control is also nega-
tive. An additional optional control using DNA from
untransduced cells (UT) is also negative. B) In con-
trast, when the transduced cells are infected with
mycoplasma, a characteristic banding pattern is ob-
served in all of the samples, except the Dpn- and the
Lig- controls, as the mycoplasma sequences out-
compete the rest. The presence of products in the UT
controls shows that the contamination was present in
the cells before the experiment started.
Fig. 7. Example genome browser (IGV) representa-
tion of Lamin B1-DamID in primary mouse hepato-
cytes under two different conditions (Exp1 and
Exp2). The genome is represented as individual DpnI
fragments with signal corresponding to the value
log2 (Lamin B1-Dam/Dam alone). This generates a
pattern of LADs (positive signal) separated by
interLADs. DamID profiles shown after smoothing by
20 fragments.
Table 1
Lamin B1-DamID sequencing data in primary mouse hepatocytes. Despite a
healthy initial number of sequence reads, mapping quality was variable, as was
the number of contaminant mitochondrial sequences. 'n total': number of se-
quences received from BGI; 'n chrs': number that map to reference chromosomal
alignments; 'n chrM': number of mitochondrial sequences; '% chrM': percentage
of mapped sequences that are mitochondrial; 'n final': number of sequences that
map unambiguously to the reference genome excluding mitochondria. All
numbers are in millions.
n total n chrs n chrM % chrM n post filter
Exp. 1 Lamin B1-Dam 49.8 44.0 5.1 11.5 38.8
Dam-alone 48.7 26.3 1.9 7.2 24.4
Exp. 2 Lamin B1-Dam 35.6 25.9 5.9 22.8 20
Dam-alone 38.4 18.8 5.0 26.4 13.8
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experiment can be smoothed by substituting the value of each DpnI
fragment by the average of n fragments surrounding it. This cleans up
the profiles, but it also reduces dynamic range and spatial resolution.
The median DpnI fragment size is 260 bp, with the 95th percentile at
just over 1.2 Kb, meaning that even smoothing by 20 fragments, we
should only be a few Kb off when calculating boundaries, which will
typically make little differences as LADs tend to be tens to hundreds of
Kb long. Fig. 8B shows the effect of increased smoothing on a noisy
interLAD.
3.4. Determination of LADs
LAD coordinates are generally determined from DamID profiles
(representing the ratio of Lamin B1-Dam to Dam alone signal) using a
peak finding algorithm. There are many suitable for the task, each with
their own pros and cons. For example, Spatial Clustering for
Identification of ChIP-Enriched Regions (SICER) was created mostly to
identify histone modification marks in chromatin, which are generally
regions much smaller than LADs and with sharper boundaries [51]. This
method has been used successfully for the detection of LADs although it
produces a large number of small sized peaks that require careful post-
processing, which can often result in missing some of the more subtle
LADs [3,13]. Another method, Enriched Domain Detector (EDD), was
created for the purpose of detecting LADs, and excels at detecting larger
genomic regions [52]. However, in our hands it is not sensitive enough
to detect reliably weaker LADs, and many of these weaker LADs often
change during processes that include cellular differentiation and lym-
phocyte activation [3,5,50]. In addition, it requires BAM files as input
(a file format containing compressed sequence alignment information),
which restricts the kind of manipulations that are easily performed on
the data, including normalization options. In our opinion, the circular
binary segmentation algorithm (CBS) in the Bioconductor/R package
DNAcopy, originally designed to identify genomic regions with ab-
normal copy number by comparative genomic hybridization (CGH),
Fig. 8. Effect of data smoothing. A) Exp2 is con-
siderably noisier than Exp1, due to the relatively
small number of clean reads, which is pushing the
limits at only 20million for Lamin B1-Dam, and
13million for Dam alone. Large strong LADs are ea-
sily determined visually, but weaker LADs are harder
to distinguish from the background. B) Effect of
smoothing on DamID profiles containing a strong and
a weaker interLAD. Without smoothing
(smoothing=0) the shorter and weaker interLAD1
(∼100 Kb) contains a cluster of genes and shows a
clear dominance of negative signals (pale blue) yet
there are a lot of interspersed positive signals that get
blended into the flanking LADs. A gentle smoothing
factor of 10 fragments reveals the interLAD clearly.
The boundaries do not shift noticeably even at
smoothing factors of 100. The longer interLAD2
(∼450 Kb) also cleans up considerably. (For inter-
pretation of the references to colour in this figure
legend, the reader is referred to the web version of
this article.)
Fig. 9. Lamin B1-DamID profile for mouse
primary hepatocytes over a 1.2Mb stretch of
chromosome 1. The unsmoothed DamID
profile is shown where positive values are
dark blue and negative values pale blue.
LADs calculated using CBS without
smoothing (sm=0) misses the smaller LADs
and has in general a coarser level of re-
solution. Using a smoothing level of 20
(sm=20) easily detects the smaller LADs
that would otherwise be ignored. The
bottom panel displays the segmentation
produced by CBS using various levels of
smoothing. Orange segments represent positive LaminB1 associations (LADs), and dark grey negative ones (interLADs), with white being neutral. (For interpretation
of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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gives the best results and it is also relatively straight forward to install
and use [28].CBS can be used on smoothed or unsmoothed data. It
works by segmenting the genome into regions of quasi-uniform signal.
The size of those fragments is much larger when using unsmoothed
data, which is well suited to the detection of large LADs. However,
applying CBS on smoothed data can allow for better detection of
smaller/weaker LADs (Fig. 9). Smoothing data slightly to better discern
patterns over the underlying background noise, in addition to using CBS
for detection of LADs, can be especially important when comparing
LADs between two conditions. This is because sometimes strong LADs
can be interrupted by small regions losing association with the nuclear
periphery, and a less sensitive method could miss these.
In order to compare LADs between two or more conditions, the
accepted norm has been to use a binary comparison: absence/presence
of LAD, to obtain all differential regions. The success of this approach is
highly dependent on an accurate determination of all LADs. An alter-
native approach would be to compare signal intensity differences be-
tween conditions within a window of a given length running along each
chromosome. The biological meaning of the signal intensity became
clearer when the DamID method was adapted to work in single cells
[27]. DamID intensities can be interpreted as a proxy for the probability
that a certain genomic region is located at the nuclear periphery during
the experiment, in any cell of the population. High signals would in-
dicate regions that are strongly and consistently associated with the
nuclear envelope across the cell population, while weaker signals would
correspond to regions that have a peripheral association in a subset of
the cells. Furthermore, it has been shown in an in vitro differentiation
system that DamID signals exhibit a reasonably strong inverse corre-
lation with their radial distance to the nuclear envelope [4]. This means
that a qualitative binary analysis (LAD vs. interLAD) is a very useful
starting point, as the existing literature clearly shows, but the value of
the quantitative information should not be forgotten as it can be far
more sensitive to detect changes in radial positioning.
4. Conclusion
In this work, we describe a DamID-Seq procedure optimized for
LADs identification in primary mouse hepatocytes. This approach has
enabled us to profile in vivo spatial nuclear chromatin architecture in
mouse liver cells. This methodology could be useful in order to re-
cognize key regulators of hepatic metabolic functions and could be
directly applied to assess global changes in chromatin organization and
gene positioning in primary hepatocyte cultures derived from liver-
specific NETs knockout mice.
5. Points to remember
1) The presence in the culture medium of supplements like insulin and
dexamethasone during the washing steps and culture maintenance
helps in slowing the dedifferentiation process typically displayed by
isolated hepatocytes.
2) The addition of EGF to hepatocyte culture medium induces the cells
to undergo at least one cycle of replication to allow monolayer
formation and to maintain liver-specifc organization of chromatin
architecture. Furthermore, EGF enhances the transduction efficiency
and, accordingly, the expression of Dam-Lamin B1 fusion protein to
the nuclear envelope, which results in specific DNA labeling by Dam
on target DNA sequences.
3) Lentiviral preparations could be used at higher titer since they
showed low cellular cytotoxicity in primary hepatocytes.
4) Due to the high autofluorescence of hepatocytes we suggest to
quench PFA fixed samples as described in materials and methods
section and more importantly we encourage the indispensable use of
a confocal microscope to acquire fluorescence images by finely se-
lecting excitation and emission wavelenghts for EGFP channel.
5) It is highly recommended to use up to four wells for each condition
when performing genomic DNA extraction for DamID experiments,
to ensure the collection of enough material for downstream pro-
cessing.
6) It is important to use the DNeasy blood and tissue kit. In our ex-
perience the DamID results are extremely variable when using
phenol–chloroform extractions to isolate DNA.
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